ClinicalTrials.gov record
Completed Phase 3 Interventional Results available

Multicenter Study of Antiarrhythmic Medications for Treatment of Infants With Supraventricular Tachycardia

ClinicalTrials.gov ID: NCT00390546

Public ClinicalTrials.gov record NCT00390546. Field values are reproduced from the official study page; the official ClinicalTrials.gov record remains the source of truth for eligibility, enrollment, and contact information.

ClinicalTrials.gov public records Last synced May 7, 2026, 6:48 AM EDT

Data is sourced from official ClinicalTrials.gov public API records. Always review the official ClinicalTrials.gov record for the latest information.

Study identification

NCT ID
NCT00390546
Recruitment status
Completed
Study type
Interventional
Phase
Phase 3
Lead sponsor
University of British Columbia
Other
Enrollment
72 participants

Conditions and interventions

Interventions

  • Digoxin Drug
  • Propranolol Drug

Drug

Eligibility (public fields only)

Age range
Up to 4 Months
Sex
All
Healthy volunteers
Healthy volunteers not accepted

This page does not interpret eligibility. Detailed inclusion and exclusion criteria are on the official ClinicalTrials.gov record.

Study timeline

Start date
Sep 30, 2006
Primary completion
Jul 31, 2010
Completion
Jul 31, 2011
Last update posted
Dec 12, 2017

2006 – 2011

United States locations

U.S. sites
10
U.S. states
9
U.S. cities
10
Facility City State ZIP Site status
University of Southern California - Children's Hospital of Los Angeles Los Angeles California
Children's Hospital of Orange County Orange California
The Children's Mercy Hospital Kansas City Missouri 64108
Schneider Children's Hospital New Hyde Park New York
Duke University Medical Center Durham North Carolina
Nationwide Children's Hospital Ohio Columbus Ohio
Medical University of Charleston South Carolina Charleston South Carolina
Primary Children's Medical Centre Salt Lake City Utah
Norfolk Children's Hospital of the King's Daughter's Norfolk Virginia
Northwest Pediatric Cardiology Spokane Washington

Site contact phone numbers, emails, and investigator names are intentionally not displayed here. Open the official ClinicalTrials.gov record for site contact information.

Non-U.S. locations

This page focuses on the U.S. directory. The official record also lists 4 non-U.S. sites.

About this trial record page

What this page shows
Public field values for ClinicalTrials.gov record NCT00390546, including study identification, conditions, interventions, eligibility (age, sex, healthy volunteer), timeline, and U.S. site list.
What this page does not do
No medical advice, eligibility judgments, treatment recommendations, study quality scoring, or AI-generated medical summaries. No site contact phone numbers, emails, or investigator names.
Where the data comes from
Sourced from the official ClinicalTrials.gov public API. The official record is the source of truth.
Last refresh
Last update posted Dec 12, 2017 · Synced May 7, 2026

Related: full search, browse by condition, browse by drug or therapy, browse by sponsor, browse by U.S. city.

Open the official record

The complete protocol, eligibility criteria, and contact information for NCT00390546 live on ClinicalTrials.gov.

View official ClinicalTrials.gov record →